Johnson & Johnson (JNJ) Tops Q4 EPS by 2c; Guides FY13 EPS Below Views
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/21/2026
- Nasdaq climbs over 1% as SpaceX, Super Micro improve AI sentiment
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
- Nvidia’s Huang highlights AI benefits in Berlin speech amid wider European tour
- AI bubble about to burst? Not yet, Yardeni says
- Abbott plans to spin off its nutrition unit as a standalone public company
- Alphabet shares drop ahead of earnings next week
- Supermicro raises Q1 FY2027 revenue outlook on AI demand
- Dow outperforms as Wall Street rises, healthcare stocks lead gains
- Crude Inventory Fell 3.06 Million Barrels Last Week - EIA
J&J (JNJ) Guides FY13 Reported Revs Below Consensus
January 22, 2013 9:58 AM ESTJohnson & Johnson (NYSE: JNJ) sees FY13 reported revs of $70.9 billion to $71.6 billion. The number compares with consensus views calling for FY13 revs of $72.13 billion.
Earlier, J&J said it expected FY13 EPS of $5.35-$5.45, versus the consensus of $5.49.
The... More



